Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Issuance of Common Stock

Albireo Pharma Inc Issuance of Common Stock Chart (ALBO)

Albireo Pharma Inc annual/quarterly Issuance of Common Stock from 2016 to 2020.
  • Albireo Pharma Inc Issuance of Common Stock for the quarter ending June 06, 2020 was $0m a 43.48% increase of 0m year over year
  • Albireo Pharma Inc Issuance of Common Stock for the last 12 months ending June 06, 2020 was $45m a 50.04% increase of 22m year over year
  • Albireo Pharma Inc Annual Issuance of Common Stock for 2019 was $24m a -302.73% decrease of -71m from 2018
  • Albireo Pharma Inc Annual Issuance of Common Stock for 2018 was $95m a 48.35% increase of 46m from 2017
  • Albireo Pharma Inc Annual Issuance of Common Stock for 2017 was $49m a 99.92% increase of 49m from 2016
Other Cash Flow Metrics:
  • Albireo Pharma Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-10m a 110.98% decrease of -11m year over year
  • Albireo Pharma Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-10m a 91.45% decrease of -10m year over year
  • Albireo Pharma Inc Total Revenue for the quarter ending September 09, 2018 was $0m a 100.42% increase of 0m year over year
View Chart On Koyfin

Quarterly ALBO Issuance of Common Stock Data

06/2020$0m
03/2020$43m
12/2019$1m
09/2019$0m
06/2019$21m
03/2019$1m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$94m

Annual ALBO Issuance of Common Stock Data

2019$24m
2018$95m
2017$49m
2016$0m